Clinical Trial Update: Effects of Vitamin B3 in Patients With Ataxia Telangiectasia [Phase 2]

View source ↗

Summary

Phase 2 trial update examining the effects of vitamin B3 in patients with Ataxia Telangiectasia due to ATM gene mutation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ataxia-telangiectasia

Drugs mentioned

• Vitamin B3 (niacin)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Ataxia Telangiectasia, ATM Gene Mutation | Phase 2 | Status: COMPLETED